The results of a new clinical trial have overturned the “wait and see” approach that cardiologists have long favored for symptom-free patients.
Related Posts
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation
Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency.
Payments Are Going Digital, but Many Seniors Still Rely on Cash
“We’re putting another burden on the elderly that we don’t have to,” one researcher said.
RFK Jr. Appears Unfamiliar With Key Elements of Medicare and Medicaid
In testimony to the Senate Finance Committee, Mr. Kennedy seemed to confuse the two government programs that cover more than…